Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuang Yinjie is a Traditional Chinese Medicine (TCM) liquid formulation developed by the Changshu City Hospital of Traditional Chinese Medicine for the treatment of human papillomavirus (HPV) infections. Primarily utilized as a topical or vaginal wash, it is indicated for the clearance of high-risk HPV and the management of associated conditions such as cervical intraepithelial neoplasia (CIN). The preparation leverages the synergistic effects of multiple herbal extracts to exert antiviral activity, reduce local inflammation, and modulate the mucosal immune environment of the reproductive tract. Clinical studies conducted in China have demonstrated its efficacy in promoting the regression of cervical lesions and increasing the conversion rate of HPV from positive to negative.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shuang Yinjie.